Group B streptococcus antigen

Details for Australian Patent Application No. 2003203097 (hide)

Owner ID Biomedical Corporation

Inventors Martin, Denis; Brodeur, Bernard R; Hamel, Josee; Rioux, Stephane

Agent FB Rice

Pub. Number AU-B-2003203097

PCT Number PCT/CA03/00186

PCT Pub. Number WO2003/068813

Priority 60/354,947 11.02.02 US

Filing date 11 February 2003

Wipo publication date 4 September 2003

Acceptance publication date 1 October 2009

International Classifications

G01N 33/569 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for micro-organisms, e.g. protozoa, bacteria, viruses

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 39/09 (2006.01) Medicinal preparations containing antigens or antibodies - Streptococcus

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 17/00 (2006.01) Drugs for dermatological disorders

A61P 19/00 (2006.01) Drugs for skeletal disorders

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 31/04 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07K 14/315 (2006.01) Peptides having more than 20 amino acids

C07K 19/00 (2006.01) Hybrid peptides

C12N 1/15 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/19 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12N 15/31 (2006.01) Mutation or genetic engineering - Genes encoding microbial proteins, e.g. enterotoxins

C12P 21/00 (2006.01) Preparation of peptides or proteins

C12Q 1/04 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - Determining presence or kind of micro-organism

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

Event Publications

10 April 2003 Complete Application Filed

  Priority application(s): 60/354,947 11.02.02 US

2 October 2003 Application Open to Public Inspection

  Published as AU-B-2003203097

24 February 2005 Assignment before Grant

  Shire BioChem Inc The application has been assigned to ID Biomedical Corporation

1 October 2009 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 01 Sep 2009. Address for service in Australia - FB Rice & Co Level 23 44 Market Street Sydney NSW 2000

1 October 2009 Application Accepted

  Published as AU-B-2003203097

4 February 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003203098-METHOD AND APPARATUS FOR CONTROLLING ENERGY TRANSFER BETWEEN AN ENERGY BUS AND A BATTERY SYSTEM BASED UPON BATTERY OPERATING CONDITION

2003203096-STERILISABLE PROBE FOR EXTRACTION OF VOLATILE COMPOUNDS IN LIQUIDS AND THEIR QUANTITATIVE DETERMINATION